Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 14,000 | $52.28 | $731,920.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,810 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 13,000 | $52.27 | $679,510.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508,810 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 6,300 | $52.26 | $329,238.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 521,810 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 21,100 | $52.25 | $1,102,475.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,110 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 641 | $45.80 | $29,355.56 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 6,681 | $39.50 | $263,906.85 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 72,130 | $42.50 | $3,065,366.31 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 541,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 2,610 | $52.65 | $137,416.50 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,210 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 800 | $52.64 | $42,112.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,820 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 14,700 | $52.63 | $773,661.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,620 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 300 | $52.62 | $15,786.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,320 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 3,000 | $52.61 | $157,830.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,620 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 11,500 | $52.60 | $604,900.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,620 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 6,800 | $52.59 | $357,612.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,120 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 4,000 | $52.58 | $210,320.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,920 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 500 | $52.57 | $26,285.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,920 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 2,200 | $52.56 | $115,632.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,420 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 100 | $52.54 | $5,254.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,620 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:49 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
SaleCommon shares without par value | 600 | $52.53 | $31,518.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,720 Read SEC document |
| September 12, 2007 Filed Sep 13, 2007 22:16 UTC |
Szela Mary TSenior Vice President
|
SaleCommon shares without par value | 8,327 | $52.50 | $437,167.50 |
DisclosureSEC source: 0001104659-07-068939 · a4.xml · nonDerivative · entry 1 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,574 Read SEC document |
| September 12, 2007 Filed Sep 13, 2007 22:20 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 8,000 | $52.46 | $419,648.00 |
DisclosureSEC source: 0001104659-07-068940 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,666 Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 47,547 | $0.00 Strike: $51.91 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 10 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,547 Underlying: Common shares · 47,547 shares Expires 2013-02-13 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC |
Hance Robert BSenior Vice President
|
GrantOption (right to buy) · Derivative | 18,564 | $0.00 Strike: $51.91 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,564 Underlying: Common shares · 18,564 shares Expires 2010-02-10 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,065 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,065 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 21,473 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,664 Underlying: Common shares · 21,473 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 60,792 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: Common shares · 60,792 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 13,245 | $51.60 | $683,428.76 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,041 Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC |
Hance Robert BSenior Vice President
|
Tax withholdingCommon shares without par value | 66,111 | $51.91 | $3,431,822.01 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,286 Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionCommon shares without par value | 24,538 | $32.61 | $800,211.17 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2007 Filed Sep 5, 2007 23:38 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionCommon shares without par value | 60,792 | $33.23 | $2,020,203.27 |
DisclosureSEC source: 0001104659-07-067163 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2007 Filed Sep 5, 2007 21:07 UTC |
Patton Donald V JRSenior Vice President
|
Tax withholdingCommon shares without par value | 1,225 | $51.91 | $63,589.75 |
DisclosureSEC source: 0001104659-07-067131 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,882 Read SEC document |
| August 27, 2007 Filed Aug 28, 2007 20:59 UTC |
Tyree James LExecutive Vice President
|
GrantOption (right to buy) · Derivative | 22,000 | $0.00 Strike: $52.14 | $0.00 |
DisclosureSEC source: 0001104659-07-065586 · a4.xml · derivative · entry 8 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: common shares · 22,000 shares Expires 2017-08-27 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in increments of 7,334 on 08/27/2008, 7,333 on 08/27/2009, and 7,333 on 08/27/2010. Read SEC document |
| August 27, 2007 Filed Aug 28, 2007 20:59 UTC |
Tyree James LExecutive Vice President
|
GrantOption (right to buy) · Derivative | 9,712 | $0.00 Strike: $52.53 | $0.00 |
DisclosureSEC source: 0001104659-07-065586 · a4.xml · derivative · entry 7 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,712 Underlying: common shares · 9,712 shares Expires 2013-02-13 F4 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 27, 2007 Filed Aug 28, 2007 20:59 UTC |
Tyree James LExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 11,061 | $0.00 Strike: $41.95 | $0.00 |
DisclosureSEC source: 0001104659-07-065586 · a4.xml · derivative · entry 6 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,792 Underlying: common shares · 11,061 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 27, 2007 Filed Aug 28, 2007 20:59 UTC |
Tyree James LExecutive Vice President
|
GrantCommon shares without par value | 4,000 | $52.14 | $208,560.00 |
DisclosureSEC source: 0001104659-07-065586 · a4.xml · nonDerivative · entry 4 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,708 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| August 27, 2007 Filed Aug 28, 2007 20:59 UTC |
Tyree James LExecutive Vice President
|
GrantCommon shares without par value | 5,400 | $52.14 | $281,556.00 |
DisclosureSEC source: 0001104659-07-065586 · a4.xml · nonDerivative · entry 3 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,708 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| August 27, 2007 Filed Aug 28, 2007 20:59 UTC |
Tyree James LExecutive Vice President
|
Tax withholdingCommon shares without par value | 9,712 | $52.53 | $510,171.36 |
DisclosureSEC source: 0001104659-07-065586 · a4.xml · nonDerivative · entry 2 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,308 Read SEC document |
| August 27, 2007 Filed Aug 28, 2007 20:59 UTC |
Tyree James LExecutive Vice President
|
Exercise / conversionCommon shares without par value | 11,061 | $41.95 | $464,008.95 |
DisclosureSEC source: 0001104659-07-065586 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2007 Filed Aug 29, 2007 20:51 UTC |
Szela Mary TSenior Vice President
|
GrantOption (right to buy) · Derivative | 35,500 | $0.00 Strike: $52.14 | $0.00 |
DisclosureSEC source: 0001104659-07-065957 · a4.xml · derivative · entry 4 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Shares · 35,500 shares Expires 2017-08-27 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in increments of 11,834 on 08/27/2008, 11,833 on 08/27/2009, and 11,833 on 08/27/2010. Read SEC document |
| August 27, 2007 Filed Aug 29, 2007 20:51 UTC |
Szela Mary TSenior Vice President
|
GrantCommon shares without par value | 2,000 | $52.14 | $104,280.00 |
DisclosureSEC source: 0001104659-07-065957 · a4.xml · nonDerivative · entry 2 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,901 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| August 27, 2007 Filed Aug 29, 2007 20:51 UTC |
Szela Mary TSenior Vice President
|
GrantCommon shares without par value | 7,800 | $52.14 | $406,692.00 |
DisclosureSEC source: 0001104659-07-065957 · a4.xml · nonDerivative · entry 1 Szela Mary T · CIK 0001410289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,901 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| August 22, 2007 Filed Aug 24, 2007 22:47 UTC |
Tyree James LSenior Vice President
|
GrantOption (right to buy) · Derivative | 5,111 | $0.00 Strike: $52.36 | $0.00 |
DisclosureSEC source: 0001104659-07-064933 · a4.xml · derivative · entry 10 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,111 Underlying: Common shares · 5,111 shares Expires 2014-02-19 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 22, 2007 Filed Aug 24, 2007 22:47 UTC |
Tyree James LSenior Vice President
|
GrantOption (right to buy) · Derivative | 15,473 | $0.00 Strike: $52.36 | $0.00 |
DisclosureSEC source: 0001104659-07-064933 · a4.xml · derivative · entry 9 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,473 Underlying: Common shares · 15,473 shares Expires 2010-02-10 F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 22, 2007 Filed Aug 24, 2007 22:47 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,122 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-064933 · a4.xml · derivative · entry 8 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,122 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 22, 2007 Filed Aug 24, 2007 22:47 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 7,493 | $0.00 Strike: $41.54 | $0.00 |
DisclosureSEC source: 0001104659-07-064933 · a4.xml · derivative · entry 7 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 7,493 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 22, 2007 Filed Aug 24, 2007 22:47 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 10,276 | $0.00 Strike: $40.93 | $0.00 |
DisclosureSEC source: 0001104659-07-064933 · a4.xml · derivative · entry 6 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 10,276 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 22, 2007 Filed Aug 24, 2007 22:47 UTC |
Tyree James LSenior Vice President
|
Tax withholdingCommon shares without par value | 20,584 | $52.36 | $1,077,778.24 |
DisclosureSEC source: 0001104659-07-064933 · a4.xml · nonDerivative · entry 4 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,959 Read SEC document |
| August 22, 2007 Filed Aug 24, 2007 22:47 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionCommon shares without par value | 6,122 | $41.03 | $251,196.07 |
DisclosureSEC source: 0001104659-07-064933 · a4.xml · nonDerivative · entry 3 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2007 Filed Aug 24, 2007 22:47 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionCommon shares without par value | 7,493 | $41.54 | $311,253.23 |
DisclosureSEC source: 0001104659-07-064933 · a4.xml · nonDerivative · entry 2 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2007 Filed Aug 24, 2007 22:47 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionCommon shares without par value | 10,276 | $40.93 | $420,579.21 |
DisclosureSEC source: 0001104659-07-064933 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.